Tutogen Medical, Inc. to Present at the Roth Capital Partners 2007 New York Conference

Thursday, August 30, 2007 General News J E 4
ALACHUA, Fla., Aug. 29 Tutogen Medical, Inc.(Amex: TTG), a leading manufacturer of sterile biological implant productsmade from human (allograft) and animal (xenograft) tissue, announced todaythat Guy L. Mayer, President and Chief Executive Officer, will be presentingat the Roth Capital Partners New York Investor Conference on Thursday,September 6, 2007 at 9:30 a.m. Eastern time. The conference is being held atThe Westin NY at Times Square, 270 West 43rd Street, New York, NY.

About Tutogen Medical, Inc.

Tutogen Medical, Inc. manufactures sterile biological implant productsmade from human (allograft) and animal (xenograft) tissue. Tutogen utilizesits proprietary Tutoplast Process(R) of tissue preservation and viralinactivation to manufacture and deliver sterile bio-implants used inspinal/trauma, urology, dental, ophthalmology, and general surgery procedures.The Company's Tutoplast(R) products are sold and distributed worldwide byZimmer Spine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc., DavolInc. subsidiary of C.R. Bard Inc., the Mentor Corporation (Mentor), ColoplastCorp., IOP, Inc. and through independent distributors internationally. Formore information, visit the Company's Web site at

Forward-Looking Statement Disclaimer:

This press release contains "forward-looking statements" within themeaning of the Private Securities Litigation Reform Act of 1995.Forward-looking statements typically are identified by use of terms such as"may," "will," "should," "plan," "expect," "anticipate," "estimate," andsimilar words, although some forward-looking statements are expresseddifferently. Forward-looking statements are based on management's currentexpectations and are subject to certain risks and uncertainties that couldcause actual results to differ materially from those set forth or implied byforward-looking statements. These and other risks are identified in theCompany's filings with the Securities and Exchange Commission, including theCompany's Annual Report on Form 10-K for the fiscal year ended September 30,2006. All information in this press release is as of the date hereof, and theCompany undertakes no duty to update this information unless required by law.Contacts: L. Robert Johnston, Jr. Lytham Partners, LLC Chief Financial Officer Joe Diaz Tutogen Medical, Inc. Joe Dorame 386-462-0402 Robert Blum 602-889-9700

SOURCE Tutogen Medical, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Medco to Present at the Thomas Weisel Partners Hea...
DaVita Recognizes 140 Centers Nationally in Wall o...